Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
Identifieur interne : 000702 ( Pmc/Checkpoint ); précédent : 000701; suivant : 000703Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
Auteurs : Falko Schmeisser ; Rachel Friedman ; Joseph Besho ; Vladimir Lugovtsev ; Jackeline Soto ; Wei Wang ; Carol Weiss ; Ollie Williams ; Hang Xie ; Zhiping Ye ; Jerry P. WeirSource :
- Influenza and Other Respiratory Viruses [ 1750-2640 ] ; 2012.
Abstract
Url:
DOI: 10.1111/irv.12029
PubMed: 23122228
PubMed Central: 5779835
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:5779835Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin</title>
<author><name sortKey="Schmeisser, Falko" sort="Schmeisser, Falko" uniqKey="Schmeisser F" first="Falko" last="Schmeisser">Falko Schmeisser</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Friedman, Rachel" sort="Friedman, Rachel" uniqKey="Friedman R" first="Rachel" last="Friedman">Rachel Friedman</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Besho, Joseph" sort="Besho, Joseph" uniqKey="Besho J" first="Joseph" last="Besho">Joseph Besho</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lugovtsev, Vladimir" sort="Lugovtsev, Vladimir" uniqKey="Lugovtsev V" first="Vladimir" last="Lugovtsev">Vladimir Lugovtsev</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Soto, Jackeline" sort="Soto, Jackeline" uniqKey="Soto J" first="Jackeline" last="Soto">Jackeline Soto</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Weiss, Carol" sort="Weiss, Carol" uniqKey="Weiss C" first="Carol" last="Weiss">Carol Weiss</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Williams, Ollie" sort="Williams, Ollie" uniqKey="Williams O" first="Ollie" last="Williams">Ollie Williams</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Xie, Hang" sort="Xie, Hang" uniqKey="Xie H" first="Hang" last="Xie">Hang Xie</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ye, Zhiping" sort="Ye, Zhiping" uniqKey="Ye Z" first="Zhiping" last="Ye">Zhiping Ye</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Weir, Jerry P" sort="Weir, Jerry P" uniqKey="Weir J" first="Jerry P." last="Weir">Jerry P. Weir</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23122228</idno>
<idno type="pmc">5779835</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779835</idno>
<idno type="RBID">PMC:5779835</idno>
<idno type="doi">10.1111/irv.12029</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000980</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000980</idno>
<idno type="wicri:Area/Pmc/Curation">000980</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000980</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000702</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000702</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin</title>
<author><name sortKey="Schmeisser, Falko" sort="Schmeisser, Falko" uniqKey="Schmeisser F" first="Falko" last="Schmeisser">Falko Schmeisser</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Friedman, Rachel" sort="Friedman, Rachel" uniqKey="Friedman R" first="Rachel" last="Friedman">Rachel Friedman</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Besho, Joseph" sort="Besho, Joseph" uniqKey="Besho J" first="Joseph" last="Besho">Joseph Besho</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lugovtsev, Vladimir" sort="Lugovtsev, Vladimir" uniqKey="Lugovtsev V" first="Vladimir" last="Lugovtsev">Vladimir Lugovtsev</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Soto, Jackeline" sort="Soto, Jackeline" uniqKey="Soto J" first="Jackeline" last="Soto">Jackeline Soto</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Weiss, Carol" sort="Weiss, Carol" uniqKey="Weiss C" first="Carol" last="Weiss">Carol Weiss</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Williams, Ollie" sort="Williams, Ollie" uniqKey="Williams O" first="Ollie" last="Williams">Ollie Williams</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Xie, Hang" sort="Xie, Hang" uniqKey="Xie H" first="Hang" last="Xie">Hang Xie</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ye, Zhiping" sort="Ye, Zhiping" uniqKey="Ye Z" first="Zhiping" last="Ye">Zhiping Ye</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Weir, Jerry P" sort="Weir, Jerry P" uniqKey="Weir J" first="Jerry P." last="Weir">Jerry P. Weir</name>
<affiliation><nlm:aff id="aff-1-1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Influenza and Other Respiratory Viruses</title>
<idno type="ISSN">1750-2640</idno>
<idno type="eISSN">1750-2659</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><bold>Aims and Methods </bold>
To facilitate antigenic characterization of the influenza A 2009 pandemic H1N1 [A(H1N1)pdm09] hemagglutinin (HA), we generated a panel of murine monoclonal antibodies (mAbs) using as the immunogen mammalian‐derived virus‐like particles containing the HA of the A/California/04/2009 virus. The antibodies were specific for the A/California/04/2009 HA, and individual mAbs suitable for use in several practical applications including ELISA, immunofluorescence, and Western blot analysis were identified.</p>
<p><bold>Results and Conclusions </bold>
As the panel of mAbs included antibodies with hemagglutination inhibition (HI) and virus neutralizing activities, this allowed identification and characterization of potentially important antigenic and neutralizing epitopes of the A/California/04/2009 HA and comparison of those epitopes with the HAs of other influenza viruses including seasonal H1N1 viruses as well as the A/South Carolina/1918 and A/New Jersey/1976 H1N1 viruses. Three mAbs with the highest HI and neutralizing titers were able to provide passive protection against virus challenge. Two other mAbs without HI or neutralizing activities were able to provide partial protection against challenge. HA epitopes recognized by the strongest neutralizing mAbs in the panel were identified by isolation and selection of virus escape mutants in the presence of individual mAbs. Cloned viruses resistant to HI and antibody neutralization were sequenced to identify mutations, and two unique mutations (D127E and G155E) were identified, both near the antigenic site Sa. Using human post‐vaccination sera, however, there were no differences in HI titer between A/California/04/2009 and either escape mutant, suggesting that these single mutations were not sufficient to abrogate a protective antibody response to the vaccine.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Ausubel, Fm" uniqKey="Ausubel F">FM Ausubel</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Influenza Other Respir Viruses</journal-id>
<journal-id journal-id-type="iso-abbrev">Influenza Other Respir Viruses</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1750-2659</journal-id>
<journal-id journal-id-type="publisher-id">IRV</journal-id>
<journal-title-group><journal-title>Influenza and Other Respiratory Viruses</journal-title>
</journal-title-group>
<issn pub-type="ppub">1750-2640</issn>
<issn pub-type="epub">1750-2659</issn>
<publisher><publisher-name>Blackwell Publishing Ltd</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">23122228</article-id>
<article-id pub-id-type="pmc">5779835</article-id>
<article-id pub-id-type="doi">10.1111/irv.12029</article-id>
<article-id pub-id-type="publisher-id">IRV12029</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Part 2 A(H1N1)pdm09 Papers</subject>
<subj-group subj-group-type="heading"><subject>Original Articles</subject>
</subj-group>
</subj-group>
<subj-group subj-group-type="overline"><subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin</article-title>
<alt-title alt-title-type="left-running-head">Schmeisser <italic>et al.</italic>
</alt-title>
<alt-title alt-title-type="right-running-head">2009 pandemic influenza HA antigenic epitopes</alt-title>
</title-group>
<contrib-group><contrib id="cr1" contrib-type="author"><name><surname>Schmeisser</surname>
<given-names>Falko</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr2" contrib-type="author"><name><surname>Friedman</surname>
<given-names>Rachel</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr3" contrib-type="author"><name><surname>Besho</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr4" contrib-type="author"><name><surname>Lugovtsev</surname>
<given-names>Vladimir</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr5" contrib-type="author"><name><surname>Soto</surname>
<given-names>Jackeline</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr6" contrib-type="author"><name><surname>Wang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr7" contrib-type="author"><name><surname>Weiss</surname>
<given-names>Carol</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr8" contrib-type="author"><name><surname>Williams</surname>
<given-names>Ollie</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr9" contrib-type="author"><name><surname>Xie</surname>
<given-names>Hang</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr10" contrib-type="author"><name><surname>Ye</surname>
<given-names>Zhiping</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
<contrib id="cr11" contrib-type="author"><name><surname>Weir</surname>
<given-names>Jerry P.</given-names>
</name>
<xref ref-type="aff" rid="aff-1-1"><sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff-1-1"><label><sup>1</sup>
</label>
Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Bethesda, MD, USA.</aff>
<author-notes><corresp id="correspondenceTo"> : Jerry P. Weir, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, USA. E‐mail: <email>jerry.weir@fda.hhs.gov</email>
</corresp>
</author-notes>
<pub-date pub-type="epub"><day>05</day>
<month>11</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="ppub"><month>5</month>
<year>2013</year>
</pub-date>
<volume>7</volume>
<issue>3</issue>
<issue-id pub-id-type="doi">10.1111/irv.2013.7.issue-3</issue-id>
<issue-title content-type="special-issue-title">Part 2 A(H1N1)pdm09 Papers</issue-title>
<fpage>480</fpage>
<lpage>490</lpage>
<history>Accepted 8 September 2012. Published Online 5 November 2012.</history>
<permissions><copyright-statement content-type="article-copyright">Published 2012. This article is a US Government work and is in the public domain in the USA.</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:type="simple" xlink:href="file:IRV-7-480.pdf"></self-uri>
<abstract><p><bold>Aims and Methods </bold>
To facilitate antigenic characterization of the influenza A 2009 pandemic H1N1 [A(H1N1)pdm09] hemagglutinin (HA), we generated a panel of murine monoclonal antibodies (mAbs) using as the immunogen mammalian‐derived virus‐like particles containing the HA of the A/California/04/2009 virus. The antibodies were specific for the A/California/04/2009 HA, and individual mAbs suitable for use in several practical applications including ELISA, immunofluorescence, and Western blot analysis were identified.</p>
<p><bold>Results and Conclusions </bold>
As the panel of mAbs included antibodies with hemagglutination inhibition (HI) and virus neutralizing activities, this allowed identification and characterization of potentially important antigenic and neutralizing epitopes of the A/California/04/2009 HA and comparison of those epitopes with the HAs of other influenza viruses including seasonal H1N1 viruses as well as the A/South Carolina/1918 and A/New Jersey/1976 H1N1 viruses. Three mAbs with the highest HI and neutralizing titers were able to provide passive protection against virus challenge. Two other mAbs without HI or neutralizing activities were able to provide partial protection against challenge. HA epitopes recognized by the strongest neutralizing mAbs in the panel were identified by isolation and selection of virus escape mutants in the presence of individual mAbs. Cloned viruses resistant to HI and antibody neutralization were sequenced to identify mutations, and two unique mutations (D127E and G155E) were identified, both near the antigenic site Sa. Using human post‐vaccination sera, however, there were no differences in HI titer between A/California/04/2009 and either escape mutant, suggesting that these single mutations were not sufficient to abrogate a protective antibody response to the vaccine.</p>
</abstract>
<kwd-group><kwd id="k1">Hemagglutinin</kwd>
<kwd id="k2">monoclonal antibody</kwd>
<kwd id="k3">protective epitopes</kwd>
</kwd-group>
<counts><fig-count count="2"></fig-count>
<table-count count="4"></table-count>
<page-count count="11"></page-count>
</counts>
<custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta><meta-name>cover-date</meta-name>
<meta-value>May 2013</meta-value>
</custom-meta>
<custom-meta><meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations><list></list>
<tree><noCountry><name sortKey="Besho, Joseph" sort="Besho, Joseph" uniqKey="Besho J" first="Joseph" last="Besho">Joseph Besho</name>
<name sortKey="Friedman, Rachel" sort="Friedman, Rachel" uniqKey="Friedman R" first="Rachel" last="Friedman">Rachel Friedman</name>
<name sortKey="Lugovtsev, Vladimir" sort="Lugovtsev, Vladimir" uniqKey="Lugovtsev V" first="Vladimir" last="Lugovtsev">Vladimir Lugovtsev</name>
<name sortKey="Schmeisser, Falko" sort="Schmeisser, Falko" uniqKey="Schmeisser F" first="Falko" last="Schmeisser">Falko Schmeisser</name>
<name sortKey="Soto, Jackeline" sort="Soto, Jackeline" uniqKey="Soto J" first="Jackeline" last="Soto">Jackeline Soto</name>
<name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
<name sortKey="Weir, Jerry P" sort="Weir, Jerry P" uniqKey="Weir J" first="Jerry P." last="Weir">Jerry P. Weir</name>
<name sortKey="Weiss, Carol" sort="Weiss, Carol" uniqKey="Weiss C" first="Carol" last="Weiss">Carol Weiss</name>
<name sortKey="Williams, Ollie" sort="Williams, Ollie" uniqKey="Williams O" first="Ollie" last="Williams">Ollie Williams</name>
<name sortKey="Xie, Hang" sort="Xie, Hang" uniqKey="Xie H" first="Hang" last="Xie">Hang Xie</name>
<name sortKey="Ye, Zhiping" sort="Ye, Zhiping" uniqKey="Ye Z" first="Zhiping" last="Ye">Zhiping Ye</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000702 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000702 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:5779835 |texte= Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:23122228" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |